DCPXF (DanCann Pharma AS) Total Assets: $2.01 Mil (As of Sep. 2025)


DCPXF DanCann Pharma AS DCPXF
20 GF Score
Price $10.00
GF Value $37.14
! 3 Warning Signs
View Full Analysis

What is DanCann Pharma AS Total Assets?

DanCann Pharma AS DCPXF 20 Total Assets is $2.01 Mil as of Sep. 2025. GuruFocus rates DCPXF with a GF Score™ of 20/100 and a GF Value™ of $37.14. The stock has 3 warning signs investors should review.

DanCann Pharma AS's Total Assets for the quarter that ended in Sep. 2025 was $2.01 Mil.

During the past 12 months, DanCann Pharma AS's average Total Assets Growth Rate was -20.70% per year. During the past 3 years, the average Total Assets Growth Rate was -40.10% per year. During the past 5 years, the average Total Assets Growth Rate was 32.40% per year.

During the past 7 years, DanCann Pharma AS's highest 3-Year average Total Assets Growth Rate was 1286.20%. The lowest was -40.10%. And the median was 123.35%.

Total Assets is connected with ROA %. DanCann Pharma AS's annualized ROA % for the quarter that ended in Sep. 2025 was -48.22%. Total Assets is also linked to Revenue through Asset Turnover. DanCann Pharma AS's Asset Turnover for the quarter that ended in Sep. 2025 was 0.12.

DanCann Pharma AS  (GREY:DCPXF) Total Assets Explanation

Total Assets is connected with ROA %.

DanCann Pharma AS's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=-0.984/( (2.068+2.013)/ 2 )
=-0.984/2.0405
=-48.22 %

Note: The Net Income data used here is four times the quarterly (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

DanCann Pharma AS's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=0.254/( (2.068+2.013)/ 2 )
=0.254/2.0405
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

DanCann Pharma AS Total Assets Related Terms

DanCann Pharma AS Total Assets Historical Data

* Premium members only.

The historical data trend for DanCann Pharma AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Total Assets Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial 8.10 10.48 10.49 2.55 2.34

DanCann Pharma AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.34 2.34 2.12 2.07 2.01
DCPXF
20GF Score
DanCann Pharma AS DCPXF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DanCann Pharma AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

DanCann Pharma AS's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=2.053+0.288
=2.34

DanCann Pharma AS's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=1.111+0.902
=2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $2.01 Mil mean?
DanCann Pharma AS (DCPXF) has a Total Assets of $2.01 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on DanCann Pharma AS and its competitors.
Is DanCann Pharma AS's Total Assets too high?
DanCann Pharma AS's current Total Assets is $2.01 Mil. Overall, DanCann Pharma AS has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Total Assets compare to ZTS and UTHR?
DanCann Pharma AS's Total Assets of $2.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on DanCann Pharma AS and its competitors. DanCann Pharma AS's current Total Assets is $2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (DCPXF) has a current Total Assets of $2.01 Mil. The stock's GF Value™ is $37.14, compared to a current price of $10.00 — trading 73.1% below its estimated fair value. The current Total Assets is $2.01 Mil. DanCann Pharma AS's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For DanCann Pharma AS (DCPXF), the current Total Assets is $2.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DanCann Pharma AS (DCPXF) Overvalued in 2026?

Based on GuruFocus' analysis, DanCann Pharma AS stock appears to be undervalued. The current stock price of $10.00 is trading 73.1% below its estimated GF Value™ of $37.14.

Key valuation signals for DCPXF:

  • Total Assets: $2.01 Mil
  • GF Value™: $37.14 vs. price of $10.00 (73.1% below fair value)
  • GF Score™: 20/100 with 3 warning signs

No single metric tells the full story. See the DCPXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DanCann Pharma AS Business Description

Address Rugvaenget 5, Ansager, DNK, DK-6823
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
20GF Score

Get the complete analysis for DCPXF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price
$37.14
GF Value